StockRunway.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
New York, NY -- (SBWIRE) -- 10/03/2013 -- StockRunway.com issues special report on – Keryx Biopharmaceuticals(NASDAQ:KERX), Array Biopharma Inc(NASDAQ:ARRY), VIVUS, Inc.(NASDAQ:VVUS), NII Holdings Inc(NASDAQ:NIHD)
Keryx Biopharmaceuticals(NASDAQ:KERX) stock is at $10.42, up +0.29 percent from its previous close of $10.39. The stock opened the session at $10.61 and touched its highest price point at $10.92.
Stocks graphical chart shows a bullish trend during its last one month’s trading session. It remained positive with +32.4% during previous three months trade. Its recent trading volume was 4.66 million shares in comparison to its usual trading volume of 1.72 million shares. Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of renal disease in the United States.
For How Long KERX will Fight for Profitability? Read This Trend Analysis report
Array Biopharma Inc(NASDAQ:ARRY) stock is at $6.59, up +2.33 percent from its previous close of $6.44. Its today’s volume is 4.61million shares in comparison to its usual trading volume of 1.80 million shares. The stock opened the session at $6.43 and touched its highest price point at $6.63.
ARRY’s quarterly performance remained green with the percentage of +32.06, while its year to date performance showed that the stock advanced overall +77.15%. Array BioPharma Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs to treat patients afflicted with cancer and inflammatory diseases primarily in North America, Europe, and the Asia Pacific.
For How Long ARRY’s Gloss will Attract Investors? Find out via this report
VIVUS, Inc.(NASDAQ:VVUS) experienced a upsurge of +8.64% to a market valuation of $1.03B per share for previous trading session. After opening the day at $9.29 per share, volume surged to 4.53 million.
During last one month it slippedwith the percentage of -18.68. Its year to date performance remained progressive with -24.07%. VIVUS, Inc., a biopharmaceutical company, engages in developing and commercializing therapies to address unmet needs in obesity, sleep apnea, diabetes, and sexual health.
Will VVUS Continue To Move Higher? Find Out Here
NII Holdings Inc(NASDAQ:NIHD) opened its shares at the price of $6.10 for the day, its closing price was $6.47 after gaining +5.03% for the day. The company traded with the total volume of 4.48 million shares while its average trading aptitude remained 3.10 million shares. The company has total of 172.44 million outstanding shares and its total market capitalization is $1.12 Billion. NII Holdings, Inc., through its subsidiaries, provides wireless communication services under the Nextel brand name to businesses and individuals in Mexico, Brazil, Argentina, Peru, and Chile.
Why Should Investors Buy NIHD After The Recent Gain? Just Go Here and Find Out
StockRunway.com is an Elite Financial Stock website catering to individual investors, fund managers, investment bankers and equity analysts. Whether you're new to penny stocks or a seasoned veteran, you'll find all the information you will need right here! Our research is a remarkable educational tool for everyone to utilize.
Sign up TODAY and join the vast amount of investors already benefiting from the best free alerts from StockRunway's service today!
This report/release/advertisement is a commercial advertisement and is for general information purposes only. Never invest in any stock featured on our site, Press Releases or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: StockRunway.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever. Read our Full Disclaimer by visiting our website.
Read Our Full Disclaimer at: http://www.stockrunway.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)